Dr. Spiegel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
HJF-DAIDS/NIAID/NIH
5601 Fishers Lane
North Bethesda, MD 20852Phone+1 240-292-4633- Is this information wrong?
Education & Training
- NYU Grossman School of MedicineResidency, Pediatrics, 1995 - 1999
- Montefiore Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 1992 - 1995
- Freie University Berlin Faculty of MedicineClass of 1985
Certifications & Licensure
- DC State Medical License 2001 - 2024
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Infectious Diseases
Clinical Trials
Publications & Presentations
PubMed
- "It's already in your body and it's preventing": a qualitative study of African female adolescent's acceptability and preferences for proxy HIV prevention methods in C...Lauren Fynn, Katherine Gill, Melissa Wallace, Millicent Atujuna, Menna Duyver, Penelope Ngcobo, Hans Spiegel, Alex Rinehart, Sybil Hosek, Linda-Gail Bekker> ;BMC Public Health. 2023 Nov 2
- 1 citationsA Randomized Trial of Point-of-Care Early Infant HIV Diagnosis in Zambia.Carla J. Chibwesha, Katie R. Mollan, Catherine E. Ford, Aaron Shibemba, Pooja T. Saha, Mildred Lusaka, Felistas Mbewe, Andrew G. Allmon, Rose Lungu, Hans M. L. Spiegel...> ;Clinical Infectious Diseases. 2021 Oct 29
- 30 citationsTenofovir diphosphate concentrations in dried blood spots from pregnant and postpartum adolescent and young women receiving daily observed pre-exposure prophylaxis in ...Lynda Stranix-Chibanda, Peter L. Anderson, Deborah Kacanek, Sybil G. Hosek, Sharon Huang, Teacler Nematadzira, Frank Taulo, Violet Korutaro, Clemensia Nakabiito, Mayse...> ;Clinical Infectious Diseases. 2021 Oct 5
- Join now to see all
Grant Support
- ACTG 219c: Pediatric LATE Outcome Protocol, Version 30 HIV/AIDSNational Center For Research Resources2007–2008
- P1030: A Phase I/II Study Of Lopinavir/Ritonavir In HIV-1 Infected Infants <6National Center For Research Resources2006
- HIV Specific Immune Responses And Disease Progression In Pediatric HIV-1 InfectiNational Center For Research Resources2006
- ACTG 219c: Pediatric LATE Outcome Protocol, Version 40National Center For Research Resources2006
- Pactg P1006: The Effects Of Highly Active Antiretroviral Therapy (HAART)National Center For Research Resources2005–2006
- Pactg 351 Phase 1/11trial Of Cd4-1gg2 Hiv-Infected ChilNational Center For Research Resources2005
- Pactg 1045: Morphologic &Metabolic Abnormality In Hiv-Infect &Uninfect ChildNational Center For Research Resources2005
- Pactg 1030: Phase I/II Study Of Lopinavir/Ritonavir InNational Center For Research Resources2005
- Pactg 1010: Antiretroviral Therapy On Body CompositionNational Center For Research Resources2005
- P1025: Perinatal Core Protocol, Version 20National Center For Research Resources2005
- ACTG 219c: Pediatric LATE Outcomes Protocol, Version 40National Center For Research Resources2005
- Washington D.C. Consortium Pediatric AIDS Clinical TrialNational Institute Of Allergy And Infectious Diseases2001–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: